Iodine is an essential component of the thyroid hormones, which play a crucial role in brain and neurological development. At least one-third of the world's population is estimated to be iodine defi cient predominantly in developing countries. Recently concern had also been expressed about the iodine status in industrialised countries such as the UK. A recent survey of the UK iodine status found that that more than two-thirds of schoolgirls aged 14-15 years were iodine defi cient due to the reduced milk intake. Maternal iodine defi ciency in pregnancy is correlated with cognitive outcomes such as intelligence quotient and reading ability in offspring. No randomised trial data exist for iodine supplementation in mild-moderate iodine-defi cient pregnant women. It is possible to combine population interventions to reduce population salt intake with salt iodisation programmes in order to maintain adequate levels of iodine nutrition.
The importance of iodine
Iodine is an essential component of the thyroid hormones thyroxine (T4) and triiodothyronine (T3) produced by the thyroid gland, which play a crucial role in brain and neurological development. The ideal dietary allowance of iodine recommended by the World Health Organization (WHO) is 150 µg iodine per day, which increases to 200-250 µg per day in pregnancy. 1 Iodine defi ciency is recognised as a global problem with large populations at risk who are living in an environment where the soil has been deprived of iodine. This arises from past glaciation, compounded by the leaching effects of snow, water and heavy rainfall that remove iodine from the soil. The mountainous regions of Europe, the Northern Indian Subcontinent, the extensive mountain ranges of China, the Andean region in South America and the lesser ranges of Africa are all iodine defi cient. 2 In 1980 the WHO estimated that at least one-third of the world's population was iodine defi cient, predominantly those living in developing countries. 3 Endemic delayed motor and mental development has long been recognised to be associated with iodine defi ciency.
Severe iodine defi ciency may be associated with impairment in the psycho-neurological outcome in the progeny because both mother and offspring are exposed to iodine defi ciency during gestation (and the postnatal period). Controlled studies performed in iodine-defi cient regions have confi rmed that iodine supplementation eliminated new cases of delayed motor and mental development reduced infant mortality and improved cognitive function in the general population. 4 Even mild iodine defi ciency is thought to lead to reductions of 10-15 in intelligence quotient (IQ) points. 1 Iodine defi ciency remains a huge problem and many people are still defi cient despite major national and international efforts to increase iodine intake, primarily through the voluntary or mandatory iodisation of salt. The WHO estimates that two billion people, including 285 million school-age children, still have iodine defi ciency, defi ned as a urinary iodine (UI) excretion of less than 100 µg/l. 5, 6 Recent epidemiological data suggest that iodine defi ciency may also now be an emerging issue in industrialised countries such as the UK, previously thought of as iodine-suffi cient. 7 International efforts to control iodine defi ciency are slowing and reaching the onethird of the worldwide population that remains defi cient poses major challenges.
Epidemiological criteria for assessing iodine nutrition
The size of the thyroid gland changes inversely in response to alterations in iodine intake, with a lag interval that varies from a few months to several years. Goitre prevalence is an index of the degree of longstanding iodine defi ciency and is less sensitive than UI in the evaluation of a recent change in the status of iodine nutrition. However, the evaluation of goitre prevalence based on palpation has been questioned because the reproducibility of assessment by palpation is low, especially with the size estimation of smaller glands, particularly in children. Therefore, the method of choice is now ultrasonography, which is reproducible with a maximum deviation of 10%. The prevalence of goitre in iodine-replete populations is below 5%. 1, 8 UI excretion is a good marker of the recent dietary intake of iodine over days and is therefore the index of choice for evaluating the degree of iodine defi ciency. Levels have been expressed per gram of creatinine excretion but more recent studies have indicated that the creatinine level is variable depending on the general nutritional status of the population and that this contributes an independent source of variation that invalidates the ratio. In addition, urinary creatinine also decomposes after three days without refrigeration, whereas UI remains stable for months. The WHO/International Council for the Control of the Iodine Defi ciency Disorders (ICCIDD)/ United Nations Children's Fund (UNICEF) recommend that for national, school-based surveys of iodine nutrition, the median UI from a representative sample of spot urine collections from 1,200 children (30 sampling clusters of 40 children per cluster) can be used to classify a population's iodine status. 9 For epidemiological studies, a population distribution of UI is required rather than individual levels. Because the frequency distribution is usually skewed towards elevated values, the median is considered instead of the mean as indicating the status of iodine nutrition. Table 1 shows the epidemiological criteria presently recommended for assessing iodine nutrition based on median UI concentrations in school-age children. UI values can be most conveniently expressed as a range with a median or by the proportions at a series of cut off points, <20 µg/l, <50 µg/l and <100 µg/l.
Elevated serum thyrotrophin (TSH) is the most sensitive indicator of the potential risk of iodine defi ciency on brain development but is only elevated in at least moderate iodine defi ciency. Serum T4 and T3 are even less specifi c indicators of iodine defi ciency because they are modifi ed usually only in conditions of severe iodine defi ciency and are not recommended in routine assessment and monitoring. 8 Serum thyroglobulin represents a sensitive index of a state of thyroid hyperstimulation and whole blood from fi nger pricks spotted on fi lter paper cards can determine serum TSH and serum thyroglobulin. However, due to technical and fi nancial limitations these are only rarely used.
Iodine defi ciency disorders
Epidemiological studies have demonstrated that reduced iodine intake during pregnancy leads to goitrogenesis, lower free T4 concentrations and increased serum TSH in pregnant women. 1 The main change in thyroid function associated with the pregnant state is the requirement for an increased production of thyroid hormone that depends directly upon the adequate availability of dietary iodine and the underlying integrity of the thyroid. Physiological adaptation can take place when the iodine intake is adequate. When iodine intake is defi cient, pregnancy can reveal an underlying iodine restriction.
The term iodine defi ciency disorders (IDD) refers to all the ill-effects of iodine defi ciency in a population that can be prevented by ensuring that the population has an adequate intake of iodine (Table 2) . 1 Severe iodine defi ciency results in severe learning disabilities, deafness and impaired motor development. The effects of mild-to-moderate iodine defi ciency on cognition are less well known than those of moderate-tosevere defi ciency but it is assumed that there is a continuum of 19 No salt iodisation programme was adopted in the UK, unlike in other European countries. Since the 1940s, signifi cant changes in farming practice in the UK were associated with a rise in the iodine content of milk, particularly during winter months when cattle are dependent on iodine-rich artifi cial feed. In addition, successive UK governments from the 1940s encouraged increased milk consumption in schoolchildren. By the 1980s this resulted in the iodine content of milk alone being almost suffi cient to meet the recommended daily requirement of 150 µg per day and has been described as an 'accidental public health triumph'. 19 Although national monitoring of milk iodine content continued, the major concern was to avoid the harmful effects of iodine toxicity rather than defi ciency. Recently, concern has also been expressed concerning the fi nding that up to 50% of UK women of child-bearing age screened in smaller studies at single centres were iodinedefi cient. 20 A study of the iodine content of 36 different salt preparations from nine major national supermarkets in Cardiff identifi ed iodine concentrations which varied from undetectable in 32 samples to trace quantities in two. Only two samples contained meaningful concentrations of iodine (20 mg/kg) related to the prevention of iodine defi ciency. A similar pattern of iodine defi ciency has been seen in Ireland, with iodine intake being particularly low in the summer months. 20 A systematic survey of the UK iodine status in 2009 found that the median UI excretion in a sample of 737 schoolgirls was 80 µg/l and that more than two-thirds had a UI of less than 100 µg/l (Fig 1) . 21 The study focused on young female subjects aged 14-15 years who are pre-pregnancy, as in the short to medium term it is their children that are most susceptible to the adverse effects of iodine defi ciency. Milk intake was positively associated with UI (Fig 2) and as milk iodine concentrations were unchanged it was likely to be the reduced amount of milk now drunk by the population responsible for the decline in iodine status. disability with more subtle impairments of IQ and motor ability associated with less severe defi ciency.
In countries which have previously been considered iodine suffi cient, such as the US, iodised salt is used in about 70% of households. However, recent data have shown that the median UI excretion in adults declined from 320 µg/l in 1971-74 to 145 µg/l in 1988-94, and was more recently measured at 168 µg/l in 2001-2002. 10 Up to 15% of women of childbearing age, and almost 7% of them during a pregnancy, had iodine excretion levels in the range of moderate iodine defi ciency, namely below 50 µg/l. The most recent US survey data from 2009-2010 demonstrated that the US population remains iodine-suffi cient, with a median UI concentration of 144 µg/l but that the median UI concentration among pregnant women had dropped to less than 150 µg/l, indicating mild iodine defi ciency. Particular attention is therefore required to ensure that pregnant women receive an adequate iodine supply by administering multivitamin tablets containing iodine supplements, in order to achieve the WHO recommended dietary allowance of 200-250 µg iodine/day.
Mild to moderate iodine defi ciency occurs in areas that are not immediately recognised as iodine defi cient. Although the introduction of iodised salt has considerably improved the situation globally in the developing world, iodine defi ciency remains an issue in continental Europe where it is estimated that up to 50% of children live in iodine defi cient communities. 11 The iodine intake may vary markedly within a country because of signifi cant variations in the natural iodine content of food and water. This was demonstrated in Denmark where pregnant women without iodine supplements had a median iodine excretion level of 66 µg/g creatinine in Copenhagen and 33 µg/g creatinine in East Jutland. 12 As maternal T4 is crucial to fetal nervous system maturation, even modest states of iodine defi ciency could be deleterious. Data from the US, Netherlands and Tasmania suggest that the children of women with hypothyroxinaemia may have psycho-neurological defi cits and delayed mental and motor function when compared with controls. [13] [14] [15] This correlates with the studies in classic areas of iodine defi ciency where a range of psychological and neurological defi cits in children have been described during the past century, 4 but it is maternal hypothyroxinaemia rather than high serum TSH that is the clear abnormality. Thus areas previously thought to be iodine suffi cient, such as Australia and New Zealand, now have evidence of substantial gestational iodine defi ciency, which may lead to low maternal circulating T4 concentrations. 16 There were few data of the consequences of mild to moderate iodine defi ciency in older children. A recent randomised, placebocontrolled, double-blind trial in 184 children aged 10-13 years in New Zealand (median UI 63 µg/l) had demonstrated that iodine supplementation (150 µg/l daily) for 28 weeks improved perceptual reasoning, suggesting that mild iodine defi ciency may prevent children attaining their full intellectual potential. 17 Similar positive fi ndings have been observed in European children who were moderately iodine defi cient. 18 The re-emergence of iodine defi ciency in the UK Iodine defi ciency has historically been considered an issue for developing countries rather than industrialised countries such as the UK. Endemic goitre associated with iodine defi ciency was at The Avon Longitudinal Study of Parents and Children (ALSPAC) study has related maternal iodine defi ciency in pregnancy from stored urine iodine samples to cognitive outcomes, such as IQ and reading ability in offspring up to the age of nine years. 22 This study recruited pregnant women in the early 1990s from the south-west UK, collected data during pregnancy and followed the health and development of their children. The women were classifi ed as being iodine defi cient by WHO criteria (median UI concentration 92 µg/g creatinine).
Children born to mothers broadly classifi ed as iodine defi cient (<150 µg/g creatinine) based on WHO criteria were more likely to have scores in the lowest quartile for total IQ and reading accuracy even after adjustment for 21 potential confounders, including maternal education, age and breastfeeding.
Correction of iodine defi ciency
The fi ndings of the UK survey have major public health importance as the UK is now number eight on the list of the top 10 iodine-defi cient countries (based on national median UI less than 100 µg/l in children), with the greatest numbers of schoolage children with insuffi cient iodine intake in 2011. 23 Iodine defi ciency in an industrialised country presents a signifi cant challenge, as recently addressed in Australia. 24 Despite the clear benefi ts in correcting iodine defi ciency, a fear of iodineinduced thyroid dysfunction has at times delayed or limited the implementation of iodine supplementation in regions with iodine defi ciency. In adults, mild iodine defi ciency is associated with a decreased risk of overt and subclinical hypothyroidism, as well as autoimmune thyroiditis and an increased risk of non-toxic nodular goitre. 1 A sudden increase in iodine supply to those in an iodine-defi cient region may enhance thyroid autoimmunity through both a cellular and humoral immune response and may result in hypothyroidism in those with damaged thyroid glands, and hyperthyroidism in those with an underlying multinodular goitre or Graves' disease, although it is unlikely to do so if the defi ciency is not severe and if the increase is relatively small.
Large epidemiological studies from Denmark have now carefully documented the pattern of thyroid disease after introduction of iodised salt in a mildly defi cient population. 25 An initial voluntary iodine fortifi cation programme proved ineffective so a mandatory iodine fortifi cation programme of bread salt and household salt was introduced in 2000, aiming to increase the iodine intake in adults by an average of 50 µg per day. This resulted in an increase in the population median UI concentrations from 53-68 µ/l in the original cohort to 93-108 µg/l when the cohort was reassessed fi ve years later. Positive benefi ts both in terms of goitre prevalence and hyperthyroidism have been observed with small increases of both thyroid peroxidase antibodies and thyroglobulin antibody titres in all age groups, but most pronounced in young women. Other smaller cohorts studied suggest that this enhanced thyroid autoimmunity might be reversible and reduce over time. 26 It was too early in the natural history of autoimmune thyroiditis to detect an impact in terms of clinically relevant hypothyroidism, but at fi ve years a slightly higher serum TSH was seen in those subjects with positive anti-thyroid antibodies. 25 
Conclusions
In developed countries such as the UK there is a strong public health objective to lower salt intake to reduce the risk of hypertension. 10 It is estimated that only 10% of UK salt intake is added to food at the table, so dialogue with the food and salt industries to establish the feasibility of adding iodised salt to processed food is essential. While accepting the available evidence-base for salt iodisation to correct iodine defi ciency, 7 a recent UK government scoping paper from the Standing Advisory Commission on Nutrition (SACN), which advises the chief medical offi cer, has not recommended iodine supplementation in pregnancy and even still questions the methodology of the iodine status assessment in populations used by the WHO.
For the government to consider iodine prophylaxis to offset the adverse effects of iodine defi ciency, data are required to provide reassurance that at the population level the benefi ts far outweigh any disadvantages. Salt iodisation is safe, equitable, largely self-fi nancing, and extremely cost effective in an industrialised country. 7, 10 The alternative strategy is daily oral potassium iodide supplements for the most susceptible groups, such as women pre-pregnancy. However, it is accepted in the UK that only 50% of pregnancies are planned and that iodine supplementation should ideally be at least three months prior to a pregnancy. 27 No randomised trial data exist for iodine supplementation in mild-moderate iodine-defi cient pregnant women. Recent epidemiological data may be the catalyst to stimulate interest and awareness of iodine defi ciency and its correction as an issue of major public health importance in the UK. The ongoing monitoring of the population iodine status remains critically important, especially in those most at risk, such as young women. It is possible to combine population interventions to reduce population salt intake with salt iodisation programmes in order to maintain adequate levels of iodine nutrition. ■ 
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